vs
Side-by-side financial comparison of ASTRAZENECA PLC (AZN) and Oracle Corporation (ORCL). Click either name above to swap in a different company.
Oracle Corporation is the larger business by last-quarter revenue ($16.1B vs $14.5B, roughly 1.1× ASTRAZENECA PLC). Oracle Corporation runs the higher net margin — 38.2% vs 16.9%, a 21.3% gap on every dollar of revenue. On growth, Oracle Corporation posted the faster year-over-year revenue change (14.2% vs 11.7%).
AstraZeneca plc (AZ) is a Swedish-British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
An oracle is a person or thing considered to provide insight, wise counsel or prophetic predictions, most notably including precognition of the future, inspired by deities. If done through occultic means, it is a form of divination.
AZN vs ORCL — Head-to-Head
Income Statement — Q2 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.5B | $16.1B |
| Net Profit | $2.4B | $6.1B |
| Gross Margin | 82.9% | — |
| Operating Margin | 24.3% | 29.5% |
| Net Margin | 16.9% | 38.2% |
| Revenue YoY | 11.7% | 14.2% |
| Net Profit YoY | 27.0% | 94.7% |
| EPS (diluted) | $1.57 | $2.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $16.1B | ||
| Q3 25 | — | $14.9B | ||
| Q2 25 | $14.5B | $15.9B | ||
| Q1 25 | — | $14.1B | ||
| Q4 24 | — | $14.1B | ||
| Q3 24 | — | $13.3B | ||
| Q2 24 | $12.9B | $14.3B | ||
| Q1 24 | — | $13.3B |
| Q4 25 | — | $6.1B | ||
| Q3 25 | — | $2.9B | ||
| Q2 25 | $2.4B | $3.4B | ||
| Q1 25 | — | $2.9B | ||
| Q4 24 | — | $3.2B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | $1.9B | $3.1B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 82.9% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 83.1% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | 24.3% | 32.1% | ||
| Q1 25 | — | 30.8% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 30.0% | ||
| Q2 24 | 21.2% | 32.8% | ||
| Q1 24 | — | 28.2% |
| Q4 25 | — | 38.2% | ||
| Q3 25 | — | 19.6% | ||
| Q2 25 | 16.9% | 21.5% | ||
| Q1 25 | — | 20.8% | ||
| Q4 24 | — | 22.4% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | 14.9% | 22.0% | ||
| Q1 24 | — | 18.1% |
| Q4 25 | — | $2.10 | ||
| Q3 25 | — | $1.01 | ||
| Q2 25 | $1.57 | $1.19 | ||
| Q1 25 | — | $1.02 | ||
| Q4 24 | — | $1.10 | ||
| Q3 24 | — | $1.03 | ||
| Q2 24 | $1.24 | $1.11 | ||
| Q1 24 | — | $0.85 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.1B | $19.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $44.8B | $30.0B |
| Total Assets | $112.4B | $205.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $19.2B | ||
| Q3 25 | — | $10.4B | ||
| Q2 25 | $7.1B | $10.8B | ||
| Q1 25 | — | $17.4B | ||
| Q4 24 | — | $10.9B | ||
| Q3 24 | — | $10.6B | ||
| Q2 24 | $6.9B | $10.5B | ||
| Q1 24 | — | $9.5B |
| Q4 25 | — | $30.0B | ||
| Q3 25 | — | $24.2B | ||
| Q2 25 | $44.8B | $20.5B | ||
| Q1 25 | — | $16.7B | ||
| Q4 24 | — | $13.7B | ||
| Q3 24 | — | $10.8B | ||
| Q2 24 | $39.6B | $8.7B | ||
| Q1 24 | — | $5.6B |
| Q4 25 | — | $205.0B | ||
| Q3 25 | — | $180.4B | ||
| Q2 25 | $112.4B | $168.4B | ||
| Q1 25 | — | $161.4B | ||
| Q4 24 | — | $148.5B | ||
| Q3 24 | — | $144.2B | ||
| Q2 24 | $104.3B | $141.0B | ||
| Q1 24 | — | $137.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.1B |
| Free Cash FlowOCF − Capex | — | $-10.0B |
| FCF MarginFCF / Revenue | — | -62.1% |
| Capex IntensityCapex / Revenue | — | 74.9% |
| Cash ConversionOCF / Net Profit | — | 0.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.1B | ||
| Q3 25 | — | $8.1B | ||
| Q2 25 | — | $6.2B | ||
| Q1 25 | — | $5.9B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $7.4B | ||
| Q2 24 | — | $6.1B | ||
| Q1 24 | — | $5.5B |
| Q4 25 | — | $-10.0B | ||
| Q3 25 | — | $-362.0M | ||
| Q2 25 | — | $-2.9B | ||
| Q1 25 | — | $71.0M | ||
| Q4 24 | — | $-2.7B | ||
| Q3 24 | — | $5.1B | ||
| Q2 24 | — | $3.3B | ||
| Q1 24 | — | $3.8B |
| Q4 25 | — | -62.1% | ||
| Q3 25 | — | -2.4% | ||
| Q2 25 | — | -18.4% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | -19.0% | ||
| Q3 24 | — | 38.5% | ||
| Q2 24 | — | 23.0% | ||
| Q1 24 | — | 28.6% |
| Q4 25 | — | 74.9% | ||
| Q3 25 | — | 57.0% | ||
| Q2 25 | — | 57.1% | ||
| Q1 25 | — | 41.5% | ||
| Q4 24 | — | 28.2% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 19.6% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 2.78× | ||
| Q2 25 | — | 1.80× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 0.41× | ||
| Q3 24 | — | 2.54× | ||
| Q2 24 | — | 1.93× | ||
| Q1 24 | — | 2.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZN
Segment breakdown not available.
ORCL
| Software Support | $4.9B | 31% |
| Cloud Infrastructure | $4.1B | 25% |
| Cloud Applications | $3.9B | 24% |
| Services Business | $1.4B | 9% |
| Software License | $939.0M | 6% |
| Hardware Business | $776.0M | 5% |
